The EU Safeguard Clause, The Last Ditch Measure, Is Not Being Used
This article was originally published in Clinica
Executive Summary
In the EU, the Safeguard Clause – a key feature of all three of the medical device directives – allows authorities to remove unsafe devices from the national and European markets, or to restrict their use. But it has not been used in the last five years, neither for medical devices, nor IVDs. This has been confirmed to Clinica by sources close to the European Commission.
You may also be interested in...
EU Regulatory Roundup, March 2024: Busy Agenda In Broad Range Of Key Areas
March was an important month for EU medtech regulation with an interesting spread of news relating to the Medical Device and IVD Regulations, the Batteries Regulation, the Artificial Intelligence Act and more.
EU’s Revised Phthalates Guideline Features New Annexes Focused On Alternatives
The effects of phthalates, plasticizers used in many medical devices, on the human endocrine system, have long been debated. But how safe are the alternatives? Updated guidelines give more insight.
Non-Medical Brain Stimulation Devices: Could They Be Down-Classified Again In the EU?
Six types of products that do not have an intended medical purpose fall under the scope of the Medical Device Regulation. Understanding their risks is complex and subject to regular re-examination by the European Commission.